International Clinical Trial: A single-arm, exploratory clinical study of Dalpiciclib combined with letrozole in the preoperative treatment of HR-positive, HER2-negative early or locally advanced breast cancer and the exploration of key factors for prognostic evaluation

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131806) titled 'A single-arm, exploratory clinical study of Dalpiciclib combined with letrozole in the preoperative treatment of HR-positive, HER2-negative early or locally advanced breast cancer and the exploration of key factors for prognostic evaluation' on Sept. 7.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Weifang People's Hospital

Condition: Breast Cancer

Recruitment Status: Recruiting

Phase: 2

Date of First Enrollment: 2025-09-25

Target Sample Size: Experimental group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=285733...